Global Cold Sore Antiviral Drug Market Growth (Status and Outlook) 2026-2032
The global Cold Sore Antiviral Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Cold Sore Antiviral Drug Industry Forecast” looks at past sales and reviews total world Cold Sore Antiviral Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Cold Sore Antiviral Drug sales for 2026 through 2032. With Cold Sore Antiviral Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cold Sore Antiviral Drug industry.
This Insight Report provides a comprehensive analysis of the global Cold Sore Antiviral Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cold Sore Antiviral Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cold Sore Antiviral Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cold Sore Antiviral Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cold Sore Antiviral Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Cold Sore Antiviral Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Cold Sore Antiviral Drug Industry Forecast” looks at past sales and reviews total world Cold Sore Antiviral Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Cold Sore Antiviral Drug sales for 2026 through 2032. With Cold Sore Antiviral Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cold Sore Antiviral Drug industry.
This Insight Report provides a comprehensive analysis of the global Cold Sore Antiviral Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cold Sore Antiviral Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cold Sore Antiviral Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cold Sore Antiviral Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cold Sore Antiviral Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Cold Sore Antiviral Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Smear
- Oral
- Others
- Child
- Aldult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Ortho Dermatologics
- Foundation Consumer Healthcare
- Novartis
- Teva Pharmaceuticals
- Amneal Pharmaceuticals LLC
- AiCuris
- Apotex
- Aurobindo Pharma USA, Inc.
- Cipla
- Glenmark Pharmaceuticals, Inc.
- Hikma Pharmaceuticals
- HRA Pharma
- Hetero Healthcare Ltd
- Jubilant Cadista
- Merix Pharmaceutical Corp
- Sun Pharmaceutical Industries Ltd.
- Viatris
- Wockhardt
- Zydus Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cold Sore Antiviral Drug Market Size (2021-2032)
2.1.2 Cold Sore Antiviral Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cold Sore Antiviral Drug by Country/Region (2021, 2025 & 2032)
2.2 Cold Sore Antiviral Drug Segment by Type
2.2.1 Smear
2.2.2 Oral
2.2.3 Others
2.2.4 Cold Sore Antiviral Drug Market Size by Type
2.2.4.1 Cold Sore Antiviral Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
2.3 Cold Sore Antiviral Drug Segment by Application
2.3.1 Child
2.3.2 Aldult
2.3.3 Cold Sore Antiviral Drug Market Size by Application
2.3.3.1 Cold Sore Antiviral Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
3 COLD SORE ANTIVIRAL DRUG MARKET SIZE BY PLAYER
3.1 Cold Sore Antiviral Drug Market Size Market Share by Player
3.1.1 Global Cold Sore Antiviral Drug Revenue by Player (2021-2026)
3.1.2 Global Cold Sore Antiviral Drug Revenue Market Share by Player (2021-2026)
3.2 Global Cold Sore Antiviral Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COLD SORE ANTIVIRAL DRUG BY REGION
4.1 Cold Sore Antiviral Drug Market Size by Region (2021-2026)
4.2 Global Cold Sore Antiviral Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cold Sore Antiviral Drug Market Size Growth (2021-2026)
4.4 APAC Cold Sore Antiviral Drug Market Size Growth (2021-2026)
4.5 Europe Cold Sore Antiviral Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Cold Sore Antiviral Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cold Sore Antiviral Drug Market Size by Country (2021-2026)
5.2 Americas Cold Sore Antiviral Drug Market Size by Type (2021-2026)
5.3 Americas Cold Sore Antiviral Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cold Sore Antiviral Drug Market Size by Region (2021-2026)
6.2 APAC Cold Sore Antiviral Drug Market Size by Type (2021-2026)
6.3 APAC Cold Sore Antiviral Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cold Sore Antiviral Drug Market Size by Country (2021-2026)
7.2 Europe Cold Sore Antiviral Drug Market Size by Type (2021-2026)
7.3 Europe Cold Sore Antiviral Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cold Sore Antiviral Drug by Region (2021-2026)
8.2 Middle East & Africa Cold Sore Antiviral Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Cold Sore Antiviral Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COLD SORE ANTIVIRAL DRUG MARKET FORECAST
10.1 Global Cold Sore Antiviral Drug Forecast by Region (2027-2032)
10.1.1 Global Cold Sore Antiviral Drug Forecast by Region (2027-2032)
10.1.2 Americas Cold Sore Antiviral Drug Forecast
10.1.3 APAC Cold Sore Antiviral Drug Forecast
10.1.4 Europe Cold Sore Antiviral Drug Forecast
10.1.5 Middle East & Africa Cold Sore Antiviral Drug Forecast
10.2 Americas Cold Sore Antiviral Drug Forecast by Country (2027-2032)
10.2.1 United States Market Cold Sore Antiviral Drug Forecast
10.2.2 Canada Market Cold Sore Antiviral Drug Forecast
10.2.3 Mexico Market Cold Sore Antiviral Drug Forecast
10.2.4 Brazil Market Cold Sore Antiviral Drug Forecast
10.3 APAC Cold Sore Antiviral Drug Forecast by Region (2027-2032)
10.3.1 China Cold Sore Antiviral Drug Market Forecast
10.3.2 Japan Market Cold Sore Antiviral Drug Forecast
10.3.3 Korea Market Cold Sore Antiviral Drug Forecast
10.3.4 Southeast Asia Market Cold Sore Antiviral Drug Forecast
10.3.5 India Market Cold Sore Antiviral Drug Forecast
10.3.6 Australia Market Cold Sore Antiviral Drug Forecast
10.4 Europe Cold Sore Antiviral Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Cold Sore Antiviral Drug Forecast
10.4.2 France Market Cold Sore Antiviral Drug Forecast
10.4.3 UK Market Cold Sore Antiviral Drug Forecast
10.4.4 Italy Market Cold Sore Antiviral Drug Forecast
10.4.5 Russia Market Cold Sore Antiviral Drug Forecast
10.5 Middle East & Africa Cold Sore Antiviral Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Cold Sore Antiviral Drug Forecast
10.5.2 South Africa Market Cold Sore Antiviral Drug Forecast
10.5.3 Israel Market Cold Sore Antiviral Drug Forecast
10.5.4 Turkey Market Cold Sore Antiviral Drug Forecast
10.6 Global Cold Sore Antiviral Drug Forecast by Type (2027-2032)
10.7 Global Cold Sore Antiviral Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cold Sore Antiviral Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Cold Sore Antiviral Drug Product Offered
11.1.3 GlaxoSmithKline Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Ortho Dermatologics
11.2.1 Ortho Dermatologics Company Information
11.2.2 Ortho Dermatologics Cold Sore Antiviral Drug Product Offered
11.2.3 Ortho Dermatologics Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Ortho Dermatologics Main Business Overview
11.2.5 Ortho Dermatologics Latest Developments
11.3 Foundation Consumer Healthcare
11.3.1 Foundation Consumer Healthcare Company Information
11.3.2 Foundation Consumer Healthcare Cold Sore Antiviral Drug Product Offered
11.3.3 Foundation Consumer Healthcare Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Foundation Consumer Healthcare Main Business Overview
11.3.5 Foundation Consumer Healthcare Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Cold Sore Antiviral Drug Product Offered
11.4.3 Novartis Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Information
11.5.2 Teva Pharmaceuticals Cold Sore Antiviral Drug Product Offered
11.5.3 Teva Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Teva Pharmaceuticals Main Business Overview
11.5.5 Teva Pharmaceuticals Latest Developments
11.6 Amneal Pharmaceuticals LLC
11.6.1 Amneal Pharmaceuticals LLC Company Information
11.6.2 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product Offered
11.6.3 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Amneal Pharmaceuticals LLC Main Business Overview
11.6.5 Amneal Pharmaceuticals LLC Latest Developments
11.7 AiCuris
11.7.1 AiCuris Company Information
11.7.2 AiCuris Cold Sore Antiviral Drug Product Offered
11.7.3 AiCuris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AiCuris Main Business Overview
11.7.5 AiCuris Latest Developments
11.8 Apotex
11.8.1 Apotex Company Information
11.8.2 Apotex Cold Sore Antiviral Drug Product Offered
11.8.3 Apotex Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Apotex Main Business Overview
11.8.5 Apotex Latest Developments
11.9 Aurobindo Pharma USA, Inc.
11.9.1 Aurobindo Pharma USA, Inc. Company Information
11.9.2 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product Offered
11.9.3 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aurobindo Pharma USA, Inc. Main Business Overview
11.9.5 Aurobindo Pharma USA, Inc. Latest Developments
11.10 Cipla
11.10.1 Cipla Company Information
11.10.2 Cipla Cold Sore Antiviral Drug Product Offered
11.10.3 Cipla Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cipla Main Business Overview
11.10.5 Cipla Latest Developments
11.11 Glenmark Pharmaceuticals, Inc.
11.11.1 Glenmark Pharmaceuticals, Inc. Company Information
11.11.2 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product Offered
11.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Glenmark Pharmaceuticals, Inc. Main Business Overview
11.11.5 Glenmark Pharmaceuticals, Inc. Latest Developments
11.12 Hikma Pharmaceuticals
11.12.1 Hikma Pharmaceuticals Company Information
11.12.2 Hikma Pharmaceuticals Cold Sore Antiviral Drug Product Offered
11.12.3 Hikma Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Hikma Pharmaceuticals Main Business Overview
11.12.5 Hikma Pharmaceuticals Latest Developments
11.13 HRA Pharma
11.13.1 HRA Pharma Company Information
11.13.2 HRA Pharma Cold Sore Antiviral Drug Product Offered
11.13.3 HRA Pharma Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 HRA Pharma Main Business Overview
11.13.5 HRA Pharma Latest Developments
11.14 Hetero Healthcare Ltd
11.14.1 Hetero Healthcare Ltd Company Information
11.14.2 Hetero Healthcare Ltd Cold Sore Antiviral Drug Product Offered
11.14.3 Hetero Healthcare Ltd Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Hetero Healthcare Ltd Main Business Overview
11.14.5 Hetero Healthcare Ltd Latest Developments
11.15 Jubilant Cadista
11.15.1 Jubilant Cadista Company Information
11.15.2 Jubilant Cadista Cold Sore Antiviral Drug Product Offered
11.15.3 Jubilant Cadista Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Jubilant Cadista Main Business Overview
11.15.5 Jubilant Cadista Latest Developments
11.16 Merix Pharmaceutical Corp
11.16.1 Merix Pharmaceutical Corp Company Information
11.16.2 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product Offered
11.16.3 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Merix Pharmaceutical Corp Main Business Overview
11.16.5 Merix Pharmaceutical Corp Latest Developments
11.17 Sun Pharmaceutical Industries Ltd.
11.17.1 Sun Pharmaceutical Industries Ltd. Company Information
11.17.2 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product Offered
11.17.3 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
11.17.5 Sun Pharmaceutical Industries Ltd. Latest Developments
11.18 Viatris
11.18.1 Viatris Company Information
11.18.2 Viatris Cold Sore Antiviral Drug Product Offered
11.18.3 Viatris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Viatris Main Business Overview
11.18.5 Viatris Latest Developments
11.19 Wockhardt
11.19.1 Wockhardt Company Information
11.19.2 Wockhardt Cold Sore Antiviral Drug Product Offered
11.19.3 Wockhardt Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Wockhardt Main Business Overview
11.19.5 Wockhardt Latest Developments
11.20 Zydus Pharmaceuticals
11.20.1 Zydus Pharmaceuticals Company Information
11.20.2 Zydus Pharmaceuticals Cold Sore Antiviral Drug Product Offered
11.20.3 Zydus Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Zydus Pharmaceuticals Main Business Overview
11.20.5 Zydus Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cold Sore Antiviral Drug Market Size (2021-2032)
2.1.2 Cold Sore Antiviral Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cold Sore Antiviral Drug by Country/Region (2021, 2025 & 2032)
2.2 Cold Sore Antiviral Drug Segment by Type
2.2.1 Smear
2.2.2 Oral
2.2.3 Others
2.2.4 Cold Sore Antiviral Drug Market Size by Type
2.2.4.1 Cold Sore Antiviral Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
2.3 Cold Sore Antiviral Drug Segment by Application
2.3.1 Child
2.3.2 Aldult
2.3.3 Cold Sore Antiviral Drug Market Size by Application
2.3.3.1 Cold Sore Antiviral Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
3 COLD SORE ANTIVIRAL DRUG MARKET SIZE BY PLAYER
3.1 Cold Sore Antiviral Drug Market Size Market Share by Player
3.1.1 Global Cold Sore Antiviral Drug Revenue by Player (2021-2026)
3.1.2 Global Cold Sore Antiviral Drug Revenue Market Share by Player (2021-2026)
3.2 Global Cold Sore Antiviral Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 COLD SORE ANTIVIRAL DRUG BY REGION
4.1 Cold Sore Antiviral Drug Market Size by Region (2021-2026)
4.2 Global Cold Sore Antiviral Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cold Sore Antiviral Drug Market Size Growth (2021-2026)
4.4 APAC Cold Sore Antiviral Drug Market Size Growth (2021-2026)
4.5 Europe Cold Sore Antiviral Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Cold Sore Antiviral Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cold Sore Antiviral Drug Market Size by Country (2021-2026)
5.2 Americas Cold Sore Antiviral Drug Market Size by Type (2021-2026)
5.3 Americas Cold Sore Antiviral Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cold Sore Antiviral Drug Market Size by Region (2021-2026)
6.2 APAC Cold Sore Antiviral Drug Market Size by Type (2021-2026)
6.3 APAC Cold Sore Antiviral Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cold Sore Antiviral Drug Market Size by Country (2021-2026)
7.2 Europe Cold Sore Antiviral Drug Market Size by Type (2021-2026)
7.3 Europe Cold Sore Antiviral Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cold Sore Antiviral Drug by Region (2021-2026)
8.2 Middle East & Africa Cold Sore Antiviral Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Cold Sore Antiviral Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL COLD SORE ANTIVIRAL DRUG MARKET FORECAST
10.1 Global Cold Sore Antiviral Drug Forecast by Region (2027-2032)
10.1.1 Global Cold Sore Antiviral Drug Forecast by Region (2027-2032)
10.1.2 Americas Cold Sore Antiviral Drug Forecast
10.1.3 APAC Cold Sore Antiviral Drug Forecast
10.1.4 Europe Cold Sore Antiviral Drug Forecast
10.1.5 Middle East & Africa Cold Sore Antiviral Drug Forecast
10.2 Americas Cold Sore Antiviral Drug Forecast by Country (2027-2032)
10.2.1 United States Market Cold Sore Antiviral Drug Forecast
10.2.2 Canada Market Cold Sore Antiviral Drug Forecast
10.2.3 Mexico Market Cold Sore Antiviral Drug Forecast
10.2.4 Brazil Market Cold Sore Antiviral Drug Forecast
10.3 APAC Cold Sore Antiviral Drug Forecast by Region (2027-2032)
10.3.1 China Cold Sore Antiviral Drug Market Forecast
10.3.2 Japan Market Cold Sore Antiviral Drug Forecast
10.3.3 Korea Market Cold Sore Antiviral Drug Forecast
10.3.4 Southeast Asia Market Cold Sore Antiviral Drug Forecast
10.3.5 India Market Cold Sore Antiviral Drug Forecast
10.3.6 Australia Market Cold Sore Antiviral Drug Forecast
10.4 Europe Cold Sore Antiviral Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Cold Sore Antiviral Drug Forecast
10.4.2 France Market Cold Sore Antiviral Drug Forecast
10.4.3 UK Market Cold Sore Antiviral Drug Forecast
10.4.4 Italy Market Cold Sore Antiviral Drug Forecast
10.4.5 Russia Market Cold Sore Antiviral Drug Forecast
10.5 Middle East & Africa Cold Sore Antiviral Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Cold Sore Antiviral Drug Forecast
10.5.2 South Africa Market Cold Sore Antiviral Drug Forecast
10.5.3 Israel Market Cold Sore Antiviral Drug Forecast
10.5.4 Turkey Market Cold Sore Antiviral Drug Forecast
10.6 Global Cold Sore Antiviral Drug Forecast by Type (2027-2032)
10.7 Global Cold Sore Antiviral Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cold Sore Antiviral Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Cold Sore Antiviral Drug Product Offered
11.1.3 GlaxoSmithKline Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Ortho Dermatologics
11.2.1 Ortho Dermatologics Company Information
11.2.2 Ortho Dermatologics Cold Sore Antiviral Drug Product Offered
11.2.3 Ortho Dermatologics Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Ortho Dermatologics Main Business Overview
11.2.5 Ortho Dermatologics Latest Developments
11.3 Foundation Consumer Healthcare
11.3.1 Foundation Consumer Healthcare Company Information
11.3.2 Foundation Consumer Healthcare Cold Sore Antiviral Drug Product Offered
11.3.3 Foundation Consumer Healthcare Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Foundation Consumer Healthcare Main Business Overview
11.3.5 Foundation Consumer Healthcare Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Cold Sore Antiviral Drug Product Offered
11.4.3 Novartis Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Information
11.5.2 Teva Pharmaceuticals Cold Sore Antiviral Drug Product Offered
11.5.3 Teva Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Teva Pharmaceuticals Main Business Overview
11.5.5 Teva Pharmaceuticals Latest Developments
11.6 Amneal Pharmaceuticals LLC
11.6.1 Amneal Pharmaceuticals LLC Company Information
11.6.2 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product Offered
11.6.3 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Amneal Pharmaceuticals LLC Main Business Overview
11.6.5 Amneal Pharmaceuticals LLC Latest Developments
11.7 AiCuris
11.7.1 AiCuris Company Information
11.7.2 AiCuris Cold Sore Antiviral Drug Product Offered
11.7.3 AiCuris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AiCuris Main Business Overview
11.7.5 AiCuris Latest Developments
11.8 Apotex
11.8.1 Apotex Company Information
11.8.2 Apotex Cold Sore Antiviral Drug Product Offered
11.8.3 Apotex Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Apotex Main Business Overview
11.8.5 Apotex Latest Developments
11.9 Aurobindo Pharma USA, Inc.
11.9.1 Aurobindo Pharma USA, Inc. Company Information
11.9.2 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product Offered
11.9.3 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Aurobindo Pharma USA, Inc. Main Business Overview
11.9.5 Aurobindo Pharma USA, Inc. Latest Developments
11.10 Cipla
11.10.1 Cipla Company Information
11.10.2 Cipla Cold Sore Antiviral Drug Product Offered
11.10.3 Cipla Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Cipla Main Business Overview
11.10.5 Cipla Latest Developments
11.11 Glenmark Pharmaceuticals, Inc.
11.11.1 Glenmark Pharmaceuticals, Inc. Company Information
11.11.2 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product Offered
11.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Glenmark Pharmaceuticals, Inc. Main Business Overview
11.11.5 Glenmark Pharmaceuticals, Inc. Latest Developments
11.12 Hikma Pharmaceuticals
11.12.1 Hikma Pharmaceuticals Company Information
11.12.2 Hikma Pharmaceuticals Cold Sore Antiviral Drug Product Offered
11.12.3 Hikma Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Hikma Pharmaceuticals Main Business Overview
11.12.5 Hikma Pharmaceuticals Latest Developments
11.13 HRA Pharma
11.13.1 HRA Pharma Company Information
11.13.2 HRA Pharma Cold Sore Antiviral Drug Product Offered
11.13.3 HRA Pharma Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 HRA Pharma Main Business Overview
11.13.5 HRA Pharma Latest Developments
11.14 Hetero Healthcare Ltd
11.14.1 Hetero Healthcare Ltd Company Information
11.14.2 Hetero Healthcare Ltd Cold Sore Antiviral Drug Product Offered
11.14.3 Hetero Healthcare Ltd Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Hetero Healthcare Ltd Main Business Overview
11.14.5 Hetero Healthcare Ltd Latest Developments
11.15 Jubilant Cadista
11.15.1 Jubilant Cadista Company Information
11.15.2 Jubilant Cadista Cold Sore Antiviral Drug Product Offered
11.15.3 Jubilant Cadista Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Jubilant Cadista Main Business Overview
11.15.5 Jubilant Cadista Latest Developments
11.16 Merix Pharmaceutical Corp
11.16.1 Merix Pharmaceutical Corp Company Information
11.16.2 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product Offered
11.16.3 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Merix Pharmaceutical Corp Main Business Overview
11.16.5 Merix Pharmaceutical Corp Latest Developments
11.17 Sun Pharmaceutical Industries Ltd.
11.17.1 Sun Pharmaceutical Industries Ltd. Company Information
11.17.2 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product Offered
11.17.3 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
11.17.5 Sun Pharmaceutical Industries Ltd. Latest Developments
11.18 Viatris
11.18.1 Viatris Company Information
11.18.2 Viatris Cold Sore Antiviral Drug Product Offered
11.18.3 Viatris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Viatris Main Business Overview
11.18.5 Viatris Latest Developments
11.19 Wockhardt
11.19.1 Wockhardt Company Information
11.19.2 Wockhardt Cold Sore Antiviral Drug Product Offered
11.19.3 Wockhardt Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Wockhardt Main Business Overview
11.19.5 Wockhardt Latest Developments
11.20 Zydus Pharmaceuticals
11.20.1 Zydus Pharmaceuticals Company Information
11.20.2 Zydus Pharmaceuticals Cold Sore Antiviral Drug Product Offered
11.20.3 Zydus Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Zydus Pharmaceuticals Main Business Overview
11.20.5 Zydus Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cold Sore Antiviral Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cold Sore Antiviral Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Smear
Table 4. Major Players of Oral
Table 5. Major Players of Others
Table 6. Cold Sore Antiviral Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Table 9. Cold Sore Antiviral Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Table 12. Global Cold Sore Antiviral Drug Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Cold Sore Antiviral Drug Revenue Market Share by Player (2021-2026)
Table 14. Cold Sore Antiviral Drug Key Players Head office and Products Offered
Table 15. Cold Sore Antiviral Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cold Sore Antiviral Drug Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Cold Sore Antiviral Drug Market Size Market Share by Region (2021-2026)
Table 20. Global Cold Sore Antiviral Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Cold Sore Antiviral Drug Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Cold Sore Antiviral Drug Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Cold Sore Antiviral Drug Market Size Market Share by Country (2021-2026)
Table 24. Americas Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Table 26. Americas Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Table 28. APAC Cold Sore Antiviral Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Cold Sore Antiviral Drug Market Size Market Share by Region (2021-2026)
Table 30. APAC Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Cold Sore Antiviral Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Cold Sore Antiviral Drug Market Size Market Share by Country (2021-2026)
Table 34. Europe Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cold Sore Antiviral Drug Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cold Sore Antiviral Drug
Table 40. Key Market Challenges & Risks of Cold Sore Antiviral Drug
Table 41. Key Industry Trends of Cold Sore Antiviral Drug
Table 42. Global Cold Sore Antiviral Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Cold Sore Antiviral Drug Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Cold Sore Antiviral Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Cold Sore Antiviral Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. GlaxoSmithKline Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 47. GlaxoSmithKline Cold Sore Antiviral Drug Product Offered
Table 48. GlaxoSmithKline Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. GlaxoSmithKline Main Business
Table 50. GlaxoSmithKline Latest Developments
Table 51. Ortho Dermatologics Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 52. Ortho Dermatologics Cold Sore Antiviral Drug Product Offered
Table 53. Ortho Dermatologics Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Ortho Dermatologics Main Business
Table 55. Ortho Dermatologics Latest Developments
Table 56. Foundation Consumer Healthcare Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 57. Foundation Consumer Healthcare Cold Sore Antiviral Drug Product Offered
Table 58. Foundation Consumer Healthcare Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Foundation Consumer Healthcare Main Business
Table 60. Foundation Consumer Healthcare Latest Developments
Table 61. Novartis Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 62. Novartis Cold Sore Antiviral Drug Product Offered
Table 63. Novartis Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments
Table 66. Teva Pharmaceuticals Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 67. Teva Pharmaceuticals Cold Sore Antiviral Drug Product Offered
Table 68. Teva Pharmaceuticals Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Teva Pharmaceuticals Main Business
Table 70. Teva Pharmaceuticals Latest Developments
Table 71. Amneal Pharmaceuticals LLC Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 72. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product Offered
Table 73. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Amneal Pharmaceuticals LLC Main Business
Table 75. Amneal Pharmaceuticals LLC Latest Developments
Table 76. AiCuris Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 77. AiCuris Cold Sore Antiviral Drug Product Offered
Table 78. AiCuris Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. AiCuris Main Business
Table 80. AiCuris Latest Developments
Table 81. Apotex Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 82. Apotex Cold Sore Antiviral Drug Product Offered
Table 83. Apotex Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Apotex Main Business
Table 85. Apotex Latest Developments
Table 86. Aurobindo Pharma USA, Inc. Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 87. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product Offered
Table 88. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Aurobindo Pharma USA, Inc. Main Business
Table 90. Aurobindo Pharma USA, Inc. Latest Developments
Table 91. Cipla Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 92. Cipla Cold Sore Antiviral Drug Product Offered
Table 93. Cipla Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Cipla Main Business
Table 95. Cipla Latest Developments
Table 96. Glenmark Pharmaceuticals, Inc. Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 97. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product Offered
Table 98. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Glenmark Pharmaceuticals, Inc. Main Business
Table 100. Glenmark Pharmaceuticals, Inc. Latest Developments
Table 101. Hikma Pharmaceuticals Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 102. Hikma Pharmaceuticals Cold Sore Antiviral Drug Product Offered
Table 103. Hikma Pharmaceuticals Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Hikma Pharmaceuticals Main Business
Table 105. Hikma Pharmaceuticals Latest Developments
Table 106. HRA Pharma Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 107. HRA Pharma Cold Sore Antiviral Drug Product Offered
Table 108. HRA Pharma Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. HRA Pharma Main Business
Table 110. HRA Pharma Latest Developments
Table 111. Hetero Healthcare Ltd Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 112. Hetero Healthcare Ltd Cold Sore Antiviral Drug Product Offered
Table 113. Hetero Healthcare Ltd Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Hetero Healthcare Ltd Main Business
Table 115. Hetero Healthcare Ltd Latest Developments
Table 116. Jubilant Cadista Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 117. Jubilant Cadista Cold Sore Antiviral Drug Product Offered
Table 118. Jubilant Cadista Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Jubilant Cadista Main Business
Table 120. Jubilant Cadista Latest Developments
Table 121. Merix Pharmaceutical Corp Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 122. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product Offered
Table 123. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Merix Pharmaceutical Corp Main Business
Table 125. Merix Pharmaceutical Corp Latest Developments
Table 126. Sun Pharmaceutical Industries Ltd. Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 127. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product Offered
Table 128. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Sun Pharmaceutical Industries Ltd. Main Business
Table 130. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 131. Viatris Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 132. Viatris Cold Sore Antiviral Drug Product Offered
Table 133. Viatris Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Viatris Main Business
Table 135. Viatris Latest Developments
Table 136. Wockhardt Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 137. Wockhardt Cold Sore Antiviral Drug Product Offered
Table 138. Wockhardt Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Wockhardt Main Business
Table 140. Wockhardt Latest Developments
Table 141. Zydus Pharmaceuticals Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 142. Zydus Pharmaceuticals Cold Sore Antiviral Drug Product Offered
Table 143. Zydus Pharmaceuticals Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Zydus Pharmaceuticals Main Business
Table 145. Zydus Pharmaceuticals Latest Developments
Table 1. Cold Sore Antiviral Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cold Sore Antiviral Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Smear
Table 4. Major Players of Oral
Table 5. Major Players of Others
Table 6. Cold Sore Antiviral Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Table 9. Cold Sore Antiviral Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Table 12. Global Cold Sore Antiviral Drug Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Cold Sore Antiviral Drug Revenue Market Share by Player (2021-2026)
Table 14. Cold Sore Antiviral Drug Key Players Head office and Products Offered
Table 15. Cold Sore Antiviral Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cold Sore Antiviral Drug Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Cold Sore Antiviral Drug Market Size Market Share by Region (2021-2026)
Table 20. Global Cold Sore Antiviral Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Cold Sore Antiviral Drug Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Cold Sore Antiviral Drug Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Cold Sore Antiviral Drug Market Size Market Share by Country (2021-2026)
Table 24. Americas Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Table 26. Americas Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Table 28. APAC Cold Sore Antiviral Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Cold Sore Antiviral Drug Market Size Market Share by Region (2021-2026)
Table 30. APAC Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Cold Sore Antiviral Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Cold Sore Antiviral Drug Market Size Market Share by Country (2021-2026)
Table 34. Europe Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cold Sore Antiviral Drug Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cold Sore Antiviral Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cold Sore Antiviral Drug Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cold Sore Antiviral Drug
Table 40. Key Market Challenges & Risks of Cold Sore Antiviral Drug
Table 41. Key Industry Trends of Cold Sore Antiviral Drug
Table 42. Global Cold Sore Antiviral Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Cold Sore Antiviral Drug Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Cold Sore Antiviral Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Cold Sore Antiviral Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. GlaxoSmithKline Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 47. GlaxoSmithKline Cold Sore Antiviral Drug Product Offered
Table 48. GlaxoSmithKline Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. GlaxoSmithKline Main Business
Table 50. GlaxoSmithKline Latest Developments
Table 51. Ortho Dermatologics Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 52. Ortho Dermatologics Cold Sore Antiviral Drug Product Offered
Table 53. Ortho Dermatologics Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Ortho Dermatologics Main Business
Table 55. Ortho Dermatologics Latest Developments
Table 56. Foundation Consumer Healthcare Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 57. Foundation Consumer Healthcare Cold Sore Antiviral Drug Product Offered
Table 58. Foundation Consumer Healthcare Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Foundation Consumer Healthcare Main Business
Table 60. Foundation Consumer Healthcare Latest Developments
Table 61. Novartis Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 62. Novartis Cold Sore Antiviral Drug Product Offered
Table 63. Novartis Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments
Table 66. Teva Pharmaceuticals Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 67. Teva Pharmaceuticals Cold Sore Antiviral Drug Product Offered
Table 68. Teva Pharmaceuticals Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Teva Pharmaceuticals Main Business
Table 70. Teva Pharmaceuticals Latest Developments
Table 71. Amneal Pharmaceuticals LLC Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 72. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product Offered
Table 73. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Amneal Pharmaceuticals LLC Main Business
Table 75. Amneal Pharmaceuticals LLC Latest Developments
Table 76. AiCuris Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 77. AiCuris Cold Sore Antiviral Drug Product Offered
Table 78. AiCuris Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. AiCuris Main Business
Table 80. AiCuris Latest Developments
Table 81. Apotex Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 82. Apotex Cold Sore Antiviral Drug Product Offered
Table 83. Apotex Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Apotex Main Business
Table 85. Apotex Latest Developments
Table 86. Aurobindo Pharma USA, Inc. Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 87. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product Offered
Table 88. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Aurobindo Pharma USA, Inc. Main Business
Table 90. Aurobindo Pharma USA, Inc. Latest Developments
Table 91. Cipla Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 92. Cipla Cold Sore Antiviral Drug Product Offered
Table 93. Cipla Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Cipla Main Business
Table 95. Cipla Latest Developments
Table 96. Glenmark Pharmaceuticals, Inc. Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 97. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product Offered
Table 98. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Glenmark Pharmaceuticals, Inc. Main Business
Table 100. Glenmark Pharmaceuticals, Inc. Latest Developments
Table 101. Hikma Pharmaceuticals Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 102. Hikma Pharmaceuticals Cold Sore Antiviral Drug Product Offered
Table 103. Hikma Pharmaceuticals Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Hikma Pharmaceuticals Main Business
Table 105. Hikma Pharmaceuticals Latest Developments
Table 106. HRA Pharma Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 107. HRA Pharma Cold Sore Antiviral Drug Product Offered
Table 108. HRA Pharma Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. HRA Pharma Main Business
Table 110. HRA Pharma Latest Developments
Table 111. Hetero Healthcare Ltd Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 112. Hetero Healthcare Ltd Cold Sore Antiviral Drug Product Offered
Table 113. Hetero Healthcare Ltd Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Hetero Healthcare Ltd Main Business
Table 115. Hetero Healthcare Ltd Latest Developments
Table 116. Jubilant Cadista Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 117. Jubilant Cadista Cold Sore Antiviral Drug Product Offered
Table 118. Jubilant Cadista Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Jubilant Cadista Main Business
Table 120. Jubilant Cadista Latest Developments
Table 121. Merix Pharmaceutical Corp Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 122. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product Offered
Table 123. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Merix Pharmaceutical Corp Main Business
Table 125. Merix Pharmaceutical Corp Latest Developments
Table 126. Sun Pharmaceutical Industries Ltd. Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 127. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product Offered
Table 128. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Sun Pharmaceutical Industries Ltd. Main Business
Table 130. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 131. Viatris Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 132. Viatris Cold Sore Antiviral Drug Product Offered
Table 133. Viatris Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Viatris Main Business
Table 135. Viatris Latest Developments
Table 136. Wockhardt Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 137. Wockhardt Cold Sore Antiviral Drug Product Offered
Table 138. Wockhardt Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Wockhardt Main Business
Table 140. Wockhardt Latest Developments
Table 141. Zydus Pharmaceuticals Details, Company Type, Cold Sore Antiviral Drug Area Served and Its Competitors
Table 142. Zydus Pharmaceuticals Cold Sore Antiviral Drug Product Offered
Table 143. Zydus Pharmaceuticals Cold Sore Antiviral Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Zydus Pharmaceuticals Main Business
Table 145. Zydus Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Cold Sore Antiviral Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cold Sore Antiviral Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cold Sore Antiviral Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cold Sore Antiviral Drug Sales Market Share by Country/Region (2025)
Figure 8. Cold Sore Antiviral Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cold Sore Antiviral Drug Market Size Market Share by Type in 2025
Figure 10. Cold Sore Antiviral Drug in Child
Figure 11. Global Cold Sore Antiviral Drug Market: Child (2021-2026) & ($ millions)
Figure 12. Cold Sore Antiviral Drug in Aldult
Figure 13. Global Cold Sore Antiviral Drug Market: Aldult (2021-2026) & ($ millions)
Figure 14. Global Cold Sore Antiviral Drug Market Size Market Share by Application in 2025
Figure 15. Global Cold Sore Antiviral Drug Revenue Market Share by Player in 2025
Figure 16. Global Cold Sore Antiviral Drug Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cold Sore Antiviral Drug Market Size 2021-2026 ($ millions)
Figure 18. APAC Cold Sore Antiviral Drug Market Size 2021-2026 ($ millions)
Figure 19. Europe Cold Sore Antiviral Drug Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cold Sore Antiviral Drug Market Size 2021-2026 ($ millions)
Figure 21. Americas Cold Sore Antiviral Drug Value Market Share by Country in 2025
Figure 22. United States Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cold Sore Antiviral Drug Market Size Market Share by Region in 2025
Figure 27. APAC Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Figure 29. China Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cold Sore Antiviral Drug Market Size Market Share by Country in 2025
Figure 36. Europe Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cold Sore Antiviral Drug Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 52. APAC Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 53. Europe Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 55. United States Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 56. Canada Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 59. China Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 60. Japan Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 61. Korea Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 63. India Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 64. Australia Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 65. Germany Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 66. France Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 67. UK Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 68. Italy Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 69. Russia Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 72. Israel Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 74. Global Cold Sore Antiviral Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cold Sore Antiviral Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 1. Cold Sore Antiviral Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cold Sore Antiviral Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cold Sore Antiviral Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cold Sore Antiviral Drug Sales Market Share by Country/Region (2025)
Figure 8. Cold Sore Antiviral Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cold Sore Antiviral Drug Market Size Market Share by Type in 2025
Figure 10. Cold Sore Antiviral Drug in Child
Figure 11. Global Cold Sore Antiviral Drug Market: Child (2021-2026) & ($ millions)
Figure 12. Cold Sore Antiviral Drug in Aldult
Figure 13. Global Cold Sore Antiviral Drug Market: Aldult (2021-2026) & ($ millions)
Figure 14. Global Cold Sore Antiviral Drug Market Size Market Share by Application in 2025
Figure 15. Global Cold Sore Antiviral Drug Revenue Market Share by Player in 2025
Figure 16. Global Cold Sore Antiviral Drug Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cold Sore Antiviral Drug Market Size 2021-2026 ($ millions)
Figure 18. APAC Cold Sore Antiviral Drug Market Size 2021-2026 ($ millions)
Figure 19. Europe Cold Sore Antiviral Drug Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cold Sore Antiviral Drug Market Size 2021-2026 ($ millions)
Figure 21. Americas Cold Sore Antiviral Drug Value Market Share by Country in 2025
Figure 22. United States Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cold Sore Antiviral Drug Market Size Market Share by Region in 2025
Figure 27. APAC Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Figure 29. China Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cold Sore Antiviral Drug Market Size Market Share by Country in 2025
Figure 36. Europe Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cold Sore Antiviral Drug Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cold Sore Antiviral Drug Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cold Sore Antiviral Drug Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cold Sore Antiviral Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 52. APAC Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 53. Europe Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 55. United States Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 56. Canada Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 59. China Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 60. Japan Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 61. Korea Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 63. India Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 64. Australia Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 65. Germany Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 66. France Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 67. UK Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 68. Italy Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 69. Russia Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 72. Israel Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
Figure 74. Global Cold Sore Antiviral Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cold Sore Antiviral Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cold Sore Antiviral Drug Market Size 2027-2032 ($ millions)
